Understanding Nerve Damage and the Support Paradigm

Garrett Murrin, representing Radiant Life Technologies, introduces this webinar on nerve damage and neuropathy. Joined by Dr. Arzhan Surazakov, who previously managed a coMra clinic for several years, the session aims to address the common question, "Will coMra therapy work for my specific condition?"

Murrin explains that while many patients are accustomed to a "control paradigm"—where the focus is on identifying the cause of damage (such as diabetes, compression, or infection) and mitigating symptoms—this approach often leaves patients with a "wait and see" prognosis. In contrast, the "support paradigm" of coMra therapy focuses on enhancing the efficiency of the body's own self-repair processes for damaged nerve cells.

Clinical Perspectives on Neuropathy

Dr. Arzhan Surazakov shares his extensive clinical experience, noting that while the causes of neuropathy vary widely—from peripheral nerve issues to degenerative central nervous system conditions—the goal of coMra therapy remains consistent: supporting the nerve to self-repair. Dr. Surazakov highlights that this approach differs significantly from traditional pharmacological or surgical interventions. By focusing on the biological needs of the damaged cells rather than just the origin of the injury, coMra therapy offers a unique pathway for recovery. The webinar emphasizes that understanding the severity and duration of an injury is crucial for managing patient expectations and determining realistic recovery timeframes.